Cellular mechanisms of high mobility group 1 (HMGB-1) protein action in the diabetic retinopathy.
Diabetic retinopathy is one of the main microvascular complications of diabetes and remains one of the leading causes of blindness worldwide. Recent studies have revealed an important role of inflammatory and proangiogenic high mobility group 1 (HMGB-1) cytokine in diabetic retinopathy. To elucidate...
Main Authors: | Andrea Rachelle C Santos, Galina Dvoriantchikova, Yiwen Li, Ghulam Mohammad, Ahmed M Abu El-Asrar, Rong Wen, Dmitry Ivanov |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3909191?pdf=render |
Similar Items
-
High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
by: Ahmed M. Abu El-Asrar, et al.
Published: (2012-01-01) -
High mobility group box 1 (HMGB1) in COVID-19
by: Fatemeh Kafi, et al.
Published: (2021-01-01) -
Role of high mobility group box 1 (HMGB1) in SCA17 pathogenesis.
by: Li-Ching Lee, et al.
Published: (2014-01-01) -
Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats
by: Eunjin Sohn, et al.
Published: (2016-03-01) -
HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
by: Mingkun Chen, et al.
Published: (2021-03-01)